FDA Approves Antria Phase 2 Stem Cell Clinical Trials – Business Wire (press release)
|
FDA Approves Antria Phase 2 Stem Cell Clinical Trials
Business Wire (press release) INDIANA, Pa.–(BUSINESS WIRE)–Clinical research company Antria, Inc. today announced that the United States Food and Drug Administration (FDA) has approved the next step in medical research to help patients look younger using their own stem cells. |
